187 related articles for article (PubMed ID: 28838449)
1. Successful Blood Transfusion Management of a Living Donor Liver Transplant Recipient in the Presence of Anti-Jr
Kurata N; Onishi Y; Kamei H; Hori T; Komagome M; Kato C; Matsushita T; Ogura Y
Transplant Proc; 2017 Sep; 49(7):1604-1607. PubMed ID: 28838449
[TBL] [Abstract][Full Text] [Related]
2. Red cell exchange to mitigate a delayed hemolytic transfusion reaction in a patient transfused with incompatible red blood cells.
Irani MS; Karafin MS; Ernster L
J Clin Apher; 2017 Feb; 32(1):59-61. PubMed ID: 27112240
[TBL] [Abstract][Full Text] [Related]
3. Refractory Acute Antibody Mediated Rejection in Liver Transplant After Desensitization of Preformed Donor Specific Antibody-Validity of Bortezomib and Everolimus: A Case Report.
Komagome M; Maki A; Nagata R; Masuda W; Kogure R; Mitsui T; Ninomiya R; Akamatsu N; Hasegawa K; Beck Y
Transplant Proc; 2022; 54(1):147-152. PubMed ID: 34974892
[TBL] [Abstract][Full Text] [Related]
4. Retransplant as Rescue Treatment for ABO-Compatible Living-Donor Liver Transplant Related Antibody-Mediated Rejection: A Case Report.
Ho MH; Wu SY; Ou KW; Su TF; Hsieh CB
Exp Clin Transplant; 2018 Apr; 16(2):222-226. PubMed ID: 26742858
[TBL] [Abstract][Full Text] [Related]
5. Influences of Pre-formed Donor-Specific Anti-Human Leukocyte Antigen Antibodies in Living-Donor Renal Transplantation: Results With Graft Immunocomplex Capture Fluorescence Analysis.
Nakamura T; Ushigome H; Watabe K; Imanishi Y; Masuda K; Matsuyama T; Harada S; Koshino K; Iida T; Nobori S; Yoshimura N
Transplant Proc; 2017 Jun; 49(5):955-958. PubMed ID: 28583566
[TBL] [Abstract][Full Text] [Related]
6. Peri-operative third party red blood cell transfusion in renal transplantation and the risk of antibody-mediated rejection and graft loss.
Fidler S; Swaminathan R; Lim W; Ferrari P; Witt C; Christiansen FT; D'Orsogna LJ; Irish AB
Transpl Immunol; 2013 Dec; 29(1-4):22-7. PubMed ID: 24090807
[TBL] [Abstract][Full Text] [Related]
7. A Case of Live Donor Liver Transplantation in Acute-on-Chronic Liver Failure with Budd-Chiari Syndrome: Donor and Recipient with Antiphospholipid Antibody Syndrome.
Obed A; Bashir A; Jarrad A
Am J Case Rep; 2018 Jun; 19():767-772. PubMed ID: 29959308
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
[TBL] [Abstract][Full Text] [Related]
9. Successful unintentional ABO-incompatible renal transplantation: Blood group A1B donor into an A2B recipient.
Fadeyi EA; Stratta RJ; Farney AC; Pomper GJ
Am J Clin Pathol; 2014 May; 141(5):724-6. PubMed ID: 24713746
[TBL] [Abstract][Full Text] [Related]
10. Macrochimerism of donor type CD56+ CD3+ T cells in donor specific transfusion via portal vein following living related donor liver transplantation.
Sato Y; Ichida T; Watanabe H; Yamamoto S; Abo T; Hatakeyama K
Hepatogastroenterology; 2003; 50(54):2161-5. PubMed ID: 14696487
[TBL] [Abstract][Full Text] [Related]
11. Impact of post-transplant flow cytometric panel-reactive antibodies on late-onset hepatic venous outflow obstruction following pediatric living donor liver transplantation.
Urahashi T; Mizuta K; Ihara Y; Sanada Y; Wakiya T; Yamada N; Okada N
Transpl Int; 2014 Mar; 27(3):322-9. PubMed ID: 24299518
[TBL] [Abstract][Full Text] [Related]
12. DEL RBC transfusion should be avoided in particular blood recipient in East Asia due to allosensitization and ineffectiveness.
Shao CP; Wang BY; Ye SH; Zhang WL; Xu H; Zhuang NB; Wu XY; Xu HG
J Zhejiang Univ Sci B; 2012 Nov; 13(11):913-8. PubMed ID: 23125084
[TBL] [Abstract][Full Text] [Related]
13. Case report: massive postpartum transfusion of Jr(a+) red cells in the presence of anti-Jra.
Yuan S; Armour R; Reid A; Abdel-Rahman KF; Rumsey DM; Phillips M; Nester T
Immunohematology; 2005; 21(3):97-101. PubMed ID: 16178666
[TBL] [Abstract][Full Text] [Related]
14. Delayed and acute hemolytic transfusion reactions resulting from red cell antibodies and red cell-reactive HLA antibodies.
Takeuchi C; Ohto H; Miura S; Yasuda H; Ono S; Ogata T
Transfusion; 2005 Dec; 45(12):1925-9. PubMed ID: 16371045
[TBL] [Abstract][Full Text] [Related]
15. Impact of Donor-Specific Antibodies on Graft Fibrosis After Pediatric Living Donor Liver Transplantation for Biliary Atresia.
Ueno T; Zenitani M; Yamanaka H; Tanaka N; Uehara S; Tazuke Y; Bessho K; Okuyama H
Transplant Proc; 2016 May; 48(4):1095-9. PubMed ID: 27320565
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppression Free Protocol for Liver Transplant from an Identical Twin Mimicking Positive Donor-Specific Antibodies: A Case Report.
Toshida K; Toshima T; Yoshizumi T; Harada N; Itoh S; Nagao Y; Wang H; Shimagaki T; Kurihara T; Mori M
Transplant Proc; 2021 Oct; 53(8):2576-2579. PubMed ID: 34001347
[TBL] [Abstract][Full Text] [Related]
17. Living donor liver transplantation for patients immunized against human leukocyte antigen.
Shindoh J; Sugawara Y; Tamura S; Kaneko J; Yamashiki N; Aoki T; Hasegawa K; Sakamoto Y; Kokudo N
J Hepatobiliary Pancreat Sci; 2013 Mar; 20(3):279-85. PubMed ID: 22407193
[TBL] [Abstract][Full Text] [Related]
18. Does a positive lymphocyte cross-match contraindicate living-donor liver transplantation?
Hori T; Uemoto S; Takada Y; Oike F; Ogura Y; Ogawa K; Miyagawa-Hayashino A; Yurugi K; Nguyen JH; Hori Y; Chen F; Egawa H
Surgery; 2010 Jun; 147(6):840-4. PubMed ID: 20096431
[TBL] [Abstract][Full Text] [Related]
19. Living Donor Liver Transplantation in Patients with Preformed Donor-Specific Anti-Human Leukocyte Antigen Antibodies Using Preoperative Desensitization Therapy According to Intensity of Donor-Specific Antibodies: A Single-Center Study.
Ogawa K; Tamura K; Sakamoto K; Funamizu N; Honjo M; Shine M; Nishi Y; Nagaoka T; Ito C; Iwata M; Uraoka M; Takada Y
Ann Transplant; 2023 Sep; 28():e941346. PubMed ID: 37697637
[TBL] [Abstract][Full Text] [Related]
20. Heart transplantation across antibodies against human leukocyte antigen and ABO-post-transplant follow-up of donor reactive antibodies.
Bućin D; Johansson S; Lindberg LO
Xenotransplantation; 2006 Mar; 13(2):101-4. PubMed ID: 16623800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
